The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Everolimus-induced activation of latent Mycobacterium tuberculosis infection in a patient with metastatic renal cell carcinoma

  • Jeon, So-Yeon (Division of Hematology/Oncology, Department of Internal Medicine, Chonbuk National University Hospital) ;
  • Yhim, Ho-Young (Division of Hematology/Oncology, Department of Internal Medicine, Chonbuk National University Hospital) ;
  • Lee, Na-Ri (Division of Hematology/Oncology, Department of Internal Medicine, Chonbuk National University Hospital) ;
  • Song, Eun-Kee (Division of Hematology/Oncology, Department of Internal Medicine, Chonbuk National University Hospital) ;
  • Kwak, Jae-Yong (Division of Hematology/Oncology, Department of Internal Medicine, Chonbuk National University Hospital) ;
  • Yim, Chang-Yeol (Division of Hematology/Oncology, Department of Internal Medicine, Chonbuk National University Hospital)
  • Received : 2015.04.29
  • Accepted : 2015.07.08
  • Published : 2017.03.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. National Comprehensive Cancer Network. NCCN Clinical Practice Guideline in Oncology (NCCN Guidelines): Kidney Cancer [Internet]. Fort Washington (PA): National Comprehensive Cancer Network, 2014 [cited 2015 Sep 20]. Available from: http://www.nccn.org/professionals/physician_gls/pdf/kidney.pdf.
  2. Horne DJ, Narita M, Spitters CL, Parimi S, Dodson S, Limaye AP. Challenging issues in tuberculosis in solid organ transplantation. Clin Infect Dis 2013;57:1473-1482. https://doi.org/10.1093/cid/cit488
  3. Fijalkowska-Morawska JB, Jagodzinska M, Nowicki M. Pulmonary embolism and reactivation of tuberculosis during everolimus therapy in a kidney transplant recipient. Ann Transplant 2011;16:107-110. https://doi.org/10.12659/AOT.882226
  4. Singanayagam A, Manalan K, Sridhar S, et al. Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-$\alpha$ antagonist therapy. Thorax 2013;68:955-961. https://doi.org/10.1136/thoraxjnl-2013-203436
  5. Porta C, Osanto S, Ravaud A, et al. Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma. Eur J Cancer 2011;47:1287-1298. https://doi.org/10.1016/j.ejca.2011.02.014

Cited by

  1. Everolimus : Mycobacterium tuberculosis: case report vol.1649, pp.1, 2017, https://doi.org/10.1007/s40278-017-29394-0
  2. Clinical aspects of tuberculosis pleurisy in patients with cancer of various localizations vol.98, pp.2, 2017, https://doi.org/10.21292/2075-1230-2020-98-2-35-40
  3. The anti-tubercular activity of simvastatin is mediated by cholesterol-driven autophagy via the AMPK-mTORC1-TFEB axis vol.61, pp.12, 2017, https://doi.org/10.1194/jlr.ra120000895
  4. Opportunistic and Serious Infections in Patients with Neuroendocrine Tumors Treated with Everolimus: A Multicenter Study of Real-World Patients vol.111, pp.7, 2017, https://doi.org/10.1159/000508632
  5. Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment vol.13, pp.5, 2017, https://doi.org/10.3390/pharmaceutics13050592